AGA Medical Amplatzer Trial For PFO To Start By Q3, Expanding On HDE
This article was originally published in The Gray Sheet
Executive Summary
AGA Medical plans to seek full PMA approval of its Amplatzer occluder system for patent foramen ovale (PFO) following receipt of limited approval via humanitarian device exemption, announced April 10
You may also be interested in...
AGA Medical Amplatzer Duct Occluder Is 97% Effective In Closing PDA
FDA approval of AGA Medical's Amplatzer Duct Occluder requires the firm to follow 435 study participants for five years post-implant, AGA says
AGA Medical Amplatzer Duct Occluder Is 97% Effective In Closing PDA
FDA approval of AGA Medical's Amplatzer Duct Occluder requires the firm to follow 435 study participants for five years post-implant, AGA says
FDA Taps Neurologists For NMT Medical’s PFO Closure Device, First To Panel
NMT Medical's PMA filing for its StarFlex implant for the closure of patent foramen ovale will be the first device to be reviewed for that indication by FDA's Circulatory System Devices Panel, the company notes